Abstract
Lipoic acid (LA) is an organic compound that plays a key role in cellular metabolism. It participates in a posttranslational modification (PTM) named lipoylation, an event that is highly conserved and that occurs in multimeric metabolic enzymes of very distinct microorganisms such as Plasmodium sp. and Staphylococcus aureus, including pyruvate dehydrogenase (PDH) and α-ketoglutarate dehydrogenase (KDH). In this mini review, we revisit the recent literature regarding LA metabolism in Plasmodium sp. and Staphylococcus aureus, by covering the lipoate ligase proteins in both microorganisms, the role of lipoate ligase proteins and insights for possible inhibitors of lipoate ligases.
Introduction
LA {6,8-dithiooctanoic acid or 5-[(3R)-dithiolan-3-yl]pentanoic acid} is an organosulfur compound (Figure 1B and Figure 1C) that has long been reported for antioxidant effects and potential therapeutic benefits in treating a variety of diseases, such as neurodegenerative diseases, diabetes, and cardiovascular conditions (; ; ; ; ; ). In addition to its potential therapeutic effects and current use as a potential antioxidant in dietary supplementation, LA is an essential cofactor for many enzymatic reactions in key biochemical pathways. To date, LA is known to act as a cofactor in five different enzyme complexes: the glycine cleavage system (GCS), pyruvate dehydrogenase (PDH), α-ketoglutarate dehydrogenase (KGDH), branched-chain α-keto acid dehydrogenase (BCDH), and acetoin dehydrogenase (AoDH) (). The α-ketodehydrogenase-complexes contain three protein subunits, named E1, E2, and E3. LA in the free form of lipoate is attached to the E2 lysine residues or to the H protein of the GCS. Lipoate metabolism is present across different human pathogens, including Plasmodium sp., the causative agent of malaria, a tropical disease that was responsible for about 229 million cases worldwide in 2019 only, with an estimated 409,000 deaths in the same year (). Although more knowledge on lipoylation has been gained (; ; ; ), it remains an attractive topic to better understand the metabolic consequences of dysregulated lipoylation and how LA metabolism enzymes could be explored as a potential drug target in different diseases. From a chemical perspective, the disulfide bond in oxidized/reduced form provides a strong redox couple that is important for reactive oxygen species (ROS) scavenging and for the redox-dependent reactions that regulate multienzyme complexes. Examples of scavenged ROS include peroxynitrite (ONOO−), hypochlorous acid (HClO), peroxyl radical (ROO·), and hydroxyl radicals (·OH). However, evidence so far indicates that hydrogen peroxide (H2O2) is not directly scavenged by LA (). LA can also act as a chelator of Cu2+, Pb2+ and Zn2+in vitro. Therefore, LA could be potentially a treatment for diseases where these metals may play an important role in their progression (; ; ).
FIGURE 1
Lipoylation in Plasmodium falciparum
Antimalarial drug resistance still is a major health concern worldwide and poses a real threat for the control of malaria (). Two main species are responsible for the majority of malaria cases worldwide: P. vivax represents 75% of malaria cases in the Americas, while 99.7% of estimated malaria cases in Africa were caused by P. falciparum (). Lipoylation of Plasmodium proteins is an event that occurs in two different compartments of the parasite: mitochondrion and the apicoplast, a unique Apicomplexan plastid organelle that evolved from endosymbiotic events. The parasite relies both on lipoate biosynthesis and lipoate-scavenged pathways: lipoate biosynthesis takes place in the apicoplast, while scavenged lipoate from host is metabolized in the mitochondrion.
Two important P. falciparum lipoate ligases, Lipl1 and Lipl2, are known to play key roles in protein lipoylation. Lipl1 is responsible for the lipoylation of GcvH protein by employing the oxidized form of lipoate and Lipl2 is responsible for the lipoylation of the E2 subunit from BCDH and KDH. However, Lipl2 depends on the formation of dihydrolipoyl-AMP in reducing conditions to transfer the lipoyl moiety to the N-lysine residue, thereby impacting the activity of Lipl1 in a reducing environment. In oxidative decarboxylation reactions of α-ketoacid complexes, lipoate derived from LA plays a key role as a cofactor. The α-ketoacids complexes are formed by three different subunits, named E1, E2, and E3. In the case of the glycine cleavage complex (GCV), the H-protein (GcvH) serves as the lipoyl domain for lipoate. All three proteins–GcvH, E2 subunit of both BCDH and KDH (E2-BCDH and E2-KDH, respectively)–are lipoylated through lipoate covalent ligation to the lysine residue at the N-terminus of lipoate domain and they are known to be localized in the parasite mitochondrion (). In vitro lipoylation assays show that Lipl1 is required for the lipoylation of GcvH, E2-BCDH and E2-KDH (). Evidence so far indicates that the role of Lipl2 in P. falciparum is to act as a lipoyl-AMP:Nε-lysine lipoyltransferase. The intermediate lipoyl-AMP generated by Lipl1 is employed by Lipl2 to lipoylate both E2-BCDH and E2-KDH. Therefore, the catalytic activity of Lipl2 also depends on the activity of Lipl1, since only Lipl1 can generate lipoyl-AMP conjugate (). Recently, Leung and colleagues et al () discussed the role of GcvH beyond GCV system, such as its possible role in the lipoylation of α-ketoacids dehydrogenase proteins. Although recent work has been performed to better elucidate the LA metabolism in eukaryotes (; ; ; ), there are still unanswered questions, such as why there are two protein ligases instead of only one protein ligase in Plasmodium and the role of lipoylated proteins in the parasite. Lipoate scavenging for use in the mitochondrion remains an open research topic to be elucidated. Scientific evidence so far indicates that lipoate scavenged from the host is important for P. falciparum erythrocytic stage parasites (). Murine malaria models and human malaria model show that lipoylation may play an essential role in Plasmodium (). In particular, an experiment in which LA analogues were utilized () showed decreased mitochondrial lipoylation and inhibition of parasite growth. A general scheme of how proteins are lipoylated in P. falciparum is briefly described in Figure 1A. Lipl1 is known to be a mitochondrial protein while Lipl2 is both mitochondrial and found in the apicoplast, a unique plastid organelle found in Apicomplexan parasites. This organelle is important in Plasmodium sp. due to the presence of important parasite metabolic pathways, such as the synthesis of isopentenyl diphosphate (IPP) (), a precursor of isoprenoids, the type II fatty acid synthesis (FAS-II) (), and the lipoate biosynthesis that is mediated by two different enzymes: octanoyl-ACP:protein N-octanoyltransferase (LipB) and lipoyl synthase (LipA) (). LipB and LipA orchestrate the biosynthesis of LA in the apicoplast: LipB is responsible for the transfer of the octanoyl-moiety to the E2 subunit whereas LipA acts as a catalyst for the insertion of two sulfurs at positions C6 and C8 of the octanoyl-moiety that is bound to the E2 subunit of the PDH in the apicoplast.
Recently, Biddau and collaborators () provided more evidence on the putative role of LA in redox regulation. Using a N-octanoyltransferase (LipB) P. falciparum 3D7 knockout strain, the authors identified upregulation of antioxidant-related cytosolic proteins that could be related to plastid-cytosol signaling. Additionally, experiments in Anopheles mosquitoes that are the vector for malaria transmission indicated that LipB knockout parasites could not produce salivary gland sporozoites, possibly indicating the need of LA synthesis in the apicoplast for the full development of P. falciparum in Anopheles.
In terms of drug discovery, the lack of the structural information available for LipA in Plasmodium sp. may also require in silico predictions, as the one available from Alphafold (). We used the FTMap web servers () for predicting protein binding hot spots through computational approaches, which shows that there are two potential hot spots, cluster 1 and cluster 2 [Figure 2C and 2(d)]. Devimistat, an LA analogue drug candidate, was chosen for investigation as a potential inhibitor compound. Molecular docking using AutoDock/Smina () was used to predict the binding-conformation of devimistat to LipA. The result shows devimistat bound to lipoic acid protein at the catalytic site of the homologous α-ketoglutarate dioxygenase of E. coli (RCSB: 1GY9, Figure 2C and 2(d). For cluster 1 (Figure 2C), there are two hydrogen bonds between serine 394, serine 393 and a compound carboxy groups hydrophobic interaction between leucine 352 and the compound 8-phenyl group, valine 152 and the compound 2-carbon atom. For cluster 2 (Figure 2D), there is a hydrogen bond between valine 255 and a compound carboxy functional group; hydrophobic interaction between isoleucine 188 and the compound 6-phenyl group; pi stacking between phenylalanine 185 and the compound 6,8-diphenyl groups.
FIGURE 2
Fatty Acid Synthesis (FAS-II) and Iron-Sulfur (Fe-S) Clusters in Plasmodium sp.
Lipids are required for Plasmodium growth and replication. The FAS-II pathway is present in the malaria parasite apicoplast, specifically in sporozoite and liver stages. Vaughan and colleagues et al.
In Plasmodium, the importance of Fe-S clusters for intraerythrocytic stage growth is well established. Fe-S clusters are found in different forms, such as 4Fe-4S. These clusters can act as cofactors and bind proteins via cysteine residues. Two proteins of the P. falciparum sulfur mobilization pathway (SUF) were characterized (
LA Metabolism in Staphylococcus aureus
Staphylococcus aureus is a gram-positive bacterium able to colonize human skin and mucous membranes, living as a commensal in healthy individuals. However, it is also capable of invasion, causing several clinical manifestations. It is a leading cause of endocarditis, bacteremia, osteomyelitis and skin and soft tissue infections (
Like in P. falciparum, S. aureus has both de novo biosynthetic pathway and salvage pathway for the generation of LA. With the exception of B. anthracis, no other pathogenic Firmicutes has such a diversity of enzymes involved in the acquisition of this cofactor (
LplA1 binds LA mainly to GcvH, while LplA2 binds LA to the E2 subunits of α-ketoacid dehydrogenases, as well as to the operon-linked GcvH-like protein, GcvH-L (
Biosynthesis of LA begins when the fatty acid intermediate octanoyl is transferred from an acyl carrier protein to the ε-amino group of a lysine in the lipoyl domain of the GcvH by the enzyme LipM. (
LA biosynthesis and its salvage pathway plays a major role in facilitating the pathogenesis of microorganisms, promoting pathogen survival within an infected host (
LA Metabolism in Humans and Other Organisms
As mentioned above, lipoylation is a PTM event that occurs in different organisms. Good drug targets must have minimal effects on the host or at least mitigation of off-target effects. The catalysis of LA assembly in human was recently elucidated by Cao and colleagueset al. (
Lipoylation events in humans remains an open research topic, since the enzymes involved in the pathway may be potential drug targets against cancer, as recently demonstrated for CPI-613® (devimistat) (
Statements
Author contributions
SY and FW wrote the manuscript, gathered literature data and provided critical suggestions. XD gathered literature data. MG provided insightful and critical revision and discussion. CW supervised the work and provided the initial suggestions.
Acknowledgments
The authors would like to thank the São Paulo Research Foundation–FAPESP for providing financial support (processes 2015/26722-8, 2017/03966-4, and 2017/26358-0) and funding from the Brazilian National Council for Scientific and Technological Development–CNPq (134005/2018-0).
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
References
1
AfanadorG. A.MatthewsK. A.BarteeD.GisselbergJ. E.WaltersM. S.Freel MeyersC. L.et al (2014). Redox-Dependent Lipoylation of Mitochondrial Proteins inPlasmodium Falciparum. Mol. Microbiol.94, 156–171. 10.1111/mmi.12753
2
AllaryM.LuJ. Z.ZhuL.PriggeS. T. (2007). Scavenging of the Cofactor Lipoate Is Essential for the Survival of the Malaria Parasite Plasmodium Falciparum. Mol. Microbiol.63, 1331–1344. 10.1111/j.1365-2958.2007.05592.x
3
AmomZ.ZakariaZ.MohamedJ.AzlanA.BahariH.Taufik Hidayat BaharuldinM.et al (2008). Lipid Lowering Effect of Antioxidant Alpha-Lipoic Acid in Experimental Atherosclerosis. J. Clin. Biochem. Nutr.43, 88–94. 10.3164/jcbn.2008051
4
BiddauM.Santha KumarT. R.HenrichP.LaineL. M.BlackburnG. J.ChokkathukalamA.et al (2021). Plasmodium Falciparum LipB Mutants Display Altered Redox and Carbon Metabolism in Asexual Stages and Cannot Complete Sporogony in Anopheles Mosquitoes. Int. J. Parasitol.51, 441–453. 10.1016/j.ijpara.2020.10.011
5
CaoX.HongY.ZhuL.HuY.CronanJ. E. (2018). Development and Retention of a Primordial Moonlighting Pathway of Protein Modification in the Absence of Selection Presents a Puzzle. Proc. Natl. Acad. Sci. USA115, 647–655. 10.1073/pnas.1718653115
6
CaoX.ZhuL.SongX.HuZ.CronanJ. E. (2018). Protein Moonlighting Elucidates the Essential Human Pathway Catalyzing Lipoic Acid Assembly on its Cognate Enzymes. Proc. Natl. Acad. Sci. USA115, E7063–E7072. 10.1073/pnas.1805862115
7
CharanM.SinghN.KumarB.SrivastavaK.SiddiqiM. I.HabibS. (2014). Sulfur Mobilization for Fe-S Cluster Assembly by the Essential SUF Pathway in the Plasmodium Falciparum Apicoplast and its Inhibition. Antimicrob. Agents Chemother.58, 3389–3398. 10.1128/AAC.02711-13
8
ChristensenQ. H.CronanJ. E. (2010). Lipoic Acid Synthesis: A New Family of Octanoyltransferases Generally Annotated as Lipoate Protein Ligases. Biochemistry49, 10024–10036. 10.1021/bi101215f
9
CrawfordM. J.Thomsen-ZiegerN.RayM.SchachtnerJ.RoosD. S.SeeberF. (2006). Toxoplasma Gondii Scavenges Host-Derived Lipoic Acid Despite its De Novo Synthesis in the Apicoplast. EMBO J.25, 3214–3222. 10.1038/sj.emboj.7601189
10
DeschermeierC.HechtL.-S.BachF.RützelK.StanwayR. R.NagelA.et al (2012). Mitochondrial Lipoic Acid Scavenging Is Essential for Plasmodium Berghei Liver Stage Development. Cell Microbiol14, 416–430. 10.1111/j.1462-5822.2011.01729.x
11
DouglasP.KriekM.BryantP.RoachP. L. (2006). Lipoyl Synthase Inserts Sulfur Atoms into an Octanoyl Substrate in a Stepwise Manner. Angew. Chem. Int. Ed.45, 5197–5199. 10.1002/anie.200601910
12
FujiwaraK.TomaS.Okamura-IkedaK.MotokawaY.NakagawaA.TaniguchiH. (2005). Crystal Structure of Lipoate-Protein Ligase A from Escherichia C. J. Biol. Chem.280, 33645–33651. 10.1074/jbc.M505010200
13
GaoL.XuZ.HuangZ.TangY.YangD.HuangJ.et al (2020). CPI-613 Rewires Lipid Metabolism to Enhance Pancreatic Cancer Apoptosis via the AMPK-ACC Signaling. J. Exp. Clin. Cancer Res.39, 73. 10.1186/s13046-020-01579-x
14
GrayczykJ. P.AlonzoF. (2019). Staphylococcus A Lipoic Acid Synthesis Limits Macrophage Reactive Oxygen and Nitrogen Species Production to Promote Survival during Infection. Infect. Immun.87, e00344–19. 10.1128/IAI.00344-19
15
GrayczykJ. P.HarveyC. J.LaczkovichI.AlonzoF. (2017). A Lipoylated Metabolic Protein Released by Staphylococcus A Suppresses Macrophage Activation. Cell Host & Microbe22, 678–687. e9. 10.1016/j.chom.2017.09.004
16
GüntherS.MatuschewskiK.MüllerS. (2009). Knockout Studies Reveal an Important Role of Plasmodium Lipoic Acid Protein Ligase A1 for Asexual Blood Stage Parasite Survival. PLoS One4, e5510. 10.1371/journal.pone.0005510
17
GüntherS.StormJ.MüllerS. (2009). Plasmodium Falciparum: Organelle-Specific Acquisition of Lipoic Acid. Int. J. Biochem. Cel Biol.41, 748–752. 10.1016/j.biocel.2008.10.028
18
HaneF.LeonenkoZ. (2014). Effect of Metals on Kinetic Pathways of Amyloid-β Aggregation. Biomolecules4, 101–116. 10.3390/biom4010101
19
JumperJ.EvansR.PritzelA.GreenT.FigurnovM.RonnebergerO.et al (2021). Highly Accurate Protein Structure Prediction with AlphaFold. Nature596, 583–589. 10.1038/s41586-021-03819-2
20
KoesD. R.BaumgartnerM. P.CamachoC. J. (2013). Lessons Learned in Empirical Scoring with Smina from the CSAR 2011 Benchmarking Exercise. J. Chem. Inf. Model.53, 1893–1904. 10.1021/ci300604z
21
KozakovD.GroveL. E.HallD. R.BohnuudT.MottarellaS. E.LuoL.et al (2015). The FTMap Family of Web Servers for Determining and Characterizing Ligand-Binding Hot Spots of Proteins. Nat. Protoc.10, 733–755. 10.1038/nprot.2015.043
22
LaczkovichI.TeohW. P.FluryS.GrayczykJ. P.ZorzoliA.AlonzoF. (2018). Increased Flexibility in the Use of Exogenous Lipoic Acid byStaphylococcus Aureus. Mol. Microbiol.109, 150–168. 10.1111/mmi.13970
23
LeungK.-Y.De CastroS. C. P.GaleaG. L.CoppA. J.GreeneN. D. E. (2021). Glycine Cleavage System H Protein Is Essential for Embryonic Viability, Implying Additional Function beyond the Glycine Cleavage System. Front. Genet.12, 625120. 10.3389/fgene.2021.625120
24
LiW.YinL.SunX.WuJ.DongZ.HuK.et al (2020). Alpha-Lipoic Acid Protects against Pressure Overload-Induced Heart Failure via ALDH2-dependent Nrf1-FUNDC1 Signaling. Cell Death Dis11, 599. 10.1038/s41419-020-02805-2
25
MarangonK.DevarajS.TiroshO.PackerL.JialalI. (1999). Comparison of the Effect of α-lipoic Acid and α-tocopherol Supplementation on Measures of Oxidative Stress. Free Radic. Biol. Med.27, 1114–1121. 10.1016/S0891-5849(99)00155-0
26
McFaddenG. I.YehE. (2017). The Apicoplast: Now You See it, Now You Don't. Int. J. Parasitol.47, 137–144. 10.1016/j.ijpara.2016.08.005
27
McNeillyA. M.DavisonG. W.MurphyM. H.NadeemN.TrinickT.DulyE.et al (2011). Effect of α-lipoic Acid and Exercise Training on Cardiovascular Disease Risk in Obesity with Impaired Glucose Tolerance. Lipids Health Dis.10, 217. 10.1186/1476-511X-10-217
28
MolzP.de FreitasB. S.UbertiV. H.da CostaK. M.KistL. W.BogoM. R.et al (2021). Effects of Lipoic Acid Supplementation on Age- and Iron-Induced Memory Impairment, Mitochondrial DNA Damage and Antioxidant Responses. Eur. J. Nutr.60, 3679–3690. 10.1007/s00394-021-02541-z
29
OppenheimR. D.CreekD. J.MacraeJ. I.ModrzynskaK. K.PinoP.LimenitakisJ.et al (2014). BCKDH: The Missing Link in Apicomplexan Mitochondrial Metabolism Is Required for Full Virulence of Toxoplasma Gondii and Plasmodium Berghei. Plos Pathog.10, e1004263. 10.1371/journal.ppat.1004263
30
PalaZ. R.SaxenaV.SagguG. S.ManiS. K.PareekR. P.KocharS. K.et al (2019). Functional Analysis of Iron-Sulfur Cluster Biogenesis (SUF Pathway) from Plasmodium Vivax Clinical Isolates. Exp. Parasitol.198, 53–62. 10.1016/j.exppara.2019.01.015
31
PietikäinenL. P.RahmanM. T.HiltunenJ. K.DieckmannC. L.KastaniotisA. J. (2021). Genetic Dissection of the Mitochondrial Lipoylation Pathway in Yeast. BMC Biol.19, 14. 10.1186/s12915-021-00951-3
32
RackJ. G. M.MorraR.BarkauskaiteE.KraehenbuehlR.ArizaA.QuY.et al (2015). Identification of a Class of Protein ADP-Ribosylating Sirtuins in Microbial Pathogens. Mol. Cel59, 309–320. 10.1016/j.molcel.2015.06.013
33
ShearsM. J.BottéC. Y.McFaddenG. I. (2015). Fatty Acid Metabolism in the Plasmodium Apicoplast: Drugs, Doubts and Knockouts. Mol. Biochem. Parasitol.199, 34–50. 10.1016/j.molbiopara.2015.03.004
34
SmirnovaJ.KabinE.JärvingI.BraginaO.TõuguV.PlitzT.et al (2018). Copper(I)-Binding Properties of De-Coppering Drugs for the Treatment of Wilson Disease. α-Lipoic Acid as a Potential Anti-Copper Agent. Sci. Rep.8, 1463. 10.1038/s41598-018-19873-2
35
SpaldingM. D.PriggeS. T. (2010). Lipoic Acid Metabolism in Microbial Pathogens. Microbiol. Mol. Biol. Rev.74, 200–228. 10.1128/MMBR.00008-10
36
StormJ.MüllerS. (2012). Lipoic Acid Metabolism of Plasmodium - A Suitable Drug Target. Curr. Pharm. Des.18, 3480–3489. 10.2174/138161212801327266
37
TangQ.GuoY.MengL.ChenX. (2021). Chemical Tagging of Protein Lipoylation. Angew. Chem. Int. Ed.60, 4028–4033. 10.1002/anie.202010981
38
TeohW. P.ChenX.LaczkovichI.AlonzoF. (2021). Staphylococcus A Adapts to the Host Nutritional Landscape to Overcome Tissue-Specific Branched-Chain Fatty Acid Requirement. Proc. Natl. Acad. Sci. USA118, e2022720118. 10.1073/pnas.2022720118
39
TeohW. P.ReskoZ. J.FluryS.AlonzoF. (2019). Dynamic Relay of Protein-Bound Lipoic Acid in Staphylococcus A. J. Bacteriol.201, e00446–19. 10.1128/JB.00446-19
40
Thomsen-ZiegerN.SchachtnerJ.SeeberF. (2003). Apicomplexan Parasites Contain a Single Lipoic Acid Synthase Located in the Plastid. FEBS Lett.547, 80–86. 10.1016/S0014-5793(03)00673-2
41
TrombaL.PerlaF.CarbottaG.ChiesaC.PacificoL. (2019). Effect of Alpha-Lipoic Acid Supplementation on Endothelial Function and Cardiovascular Risk Factors in Overweight/Obese Youths: A Double-Blind, Placebo-Controlled Randomized Trial. Nutrients11, 375. 10.3390/nu11020375
42
TurnerN. A.Sharma-KuinkelB. K.MaskarinecS. A.EichenbergerE. M.ShahP. P.CarugatiM.et al (2019). Methicillin-Resistant Staphylococcus A: An Overview of Basic and Clinical Research. Nat. Rev. Microbiol.17, 203–218. 10.1038/s41579-018-0147-4
43
VacchinaP.LambruschiD. A.UttaroA. D. (2018). Lipoic Acid Metabolism in Trypanosoma Cruzi as Putative Target for Chemotherapy. Exp. Parasitol.186, 17–23. 10.1016/j.exppara.2018.01.017
44
van HalS. J.JensenS. O.VaskaV. L.EspedidoB. A.PatersonD. L.GosbellI. B. (2012). Predictors of Mortality in Staphylococcus A Bacteremia. Clin. Microbiol. Rev.25, 362–386. 10.1128/CMR.05022-11
45
van SchaijkB. C. L.KumarT. R. S.VosM. W.RichmanA.van GemertG.-J.LiT.et al (2014). Type II Fatty Acid Biosynthesis Is Essential for Plasmodium Falciparum Sporozoite Development in the Midgut of Anopheles Mosquitoes. Eukaryot. Cel13, 550–559. 10.1128/EC.00264-13
46
VaughanA. M.O'NeillM. T.TarunA. S.CamargoN.PhuongT. M.AlyA. S. I.et al (2009). Type II Fatty Acid Synthesis Is Essential Only for Malaria Parasite Late Liver Stage Development. Cel Microbiol11, 506–520. 10.1111/j.1462-5822.2008.01270.x
47
WangM.WangQ.GaoX.SuZ. (2017). Conditional Knock-Out of Lipoic Acid Protein Ligase 1 Reveals Redundancy Pathway for Lipoic Acid Metabolism in Plasmodium Berghei Malaria Parasite. Parasites Vectors10, 315. 10.1186/s13071-017-2253-y
48
WHO (2020). Report on Antimalarial Drug Efficacy, Resistance and Response: 10 Years of Surveillance (2010-2019). Geneva, Switzerland: WHO.
49
WileyJ. D.MerinoE. F.KraiP. M.McLeanK. J.TripathiA. K.Vega-RodríguezJ.et al (2015). Isoprenoid Precursor Biosynthesis Is the Essential Metabolic Role of the Apicoplast during Gametocytogenesis in Plasmodium Falciparum. Eukaryot. Cel14, 128–139. 10.1128/EC.00198-14
50
World Health Organization (2021). Malaria - Key Facts. World Heal Organ. Available at: https://www.who.int/news-room/fact-sheets/detail/malaria (accessed June 16, 2021).
51
World Health Organization (2020). World Malaria Report 2020: 20 Years of Global Progress and Challenges. Geneva, Switzerland: World Health Organization, Licence: CC BY-NC-SA 3.0 IGO.
52
WrengerC.MüllerS. (2004). The Human Malaria Parasite Plasmodium Falciparum Has Distinct Organelle-specific Lipoylation Pathways. Mol. Microbiol.53, 103–113. 10.1111/j.1365-2958.2004.04112.x
53
XiaoY.CuiJ.ShiY.LeG. (2012). Alpha-Lipoic Acid Protects against Hydrogen Peroxide-Induced Oxidative Stress in MC3T3-E1 Osteoblast-Like Cells. J. Funct. Foods4, 642–649. 10.1016/j.jff.2012.04.004
54
ZacharZ.MarecekJ.MaturoC.GuptaS.StuartS. D.HowellK.et al (2011). Non-Redox-Active Lipoate Derivates Disrupt Cancer Cell Mitochondrial Metabolism and Are Potent Anticancer Agents In Vivo. J. Mol. Med.89, 1137–1148. 10.1007/s00109-011-0785-8
55
ZhangX.NieJ.ZhengY.RenJ.ZengA. P. (2020). Activation and Competition of Lipoylation of H Protein and its Hydrolysis in a Reaction cascade Catalyzed by the Multifunctional Enzyme Lipoate-Protein Ligase A. Biotechnol. Bioeng.117, 3677–3687. 10.1002/bit.27526
56
ZorzoliA.GrayczykJ. P.AlonzoF. (2016). Staphylococcus A Tissue Infection during Sepsis Is Supported by Differential Use of Bacterial or Host-Derived Lipoic Acid. Plos Pathog.12, e1005933. 10.1371/journal.ppat.1005933
Summary
Keywords
Lipoic acid, malaria, protein lipoylation, Plasmodium, S. aureus, Lipoic acid (LA), lipoylation
Citation
Rei Yan SL, Wakasuqui F, Du X, Groves MR and Wrenger C (2021) Lipoic Acid Metabolism as a Potential Chemotherapeutic Target Against Plasmodium falciparum and Staphylococcus aureus. Front. Chem. 9:742175. doi: 10.3389/fchem.2021.742175
Received
15 July 2021
Accepted
21 October 2021
Published
04 November 2021
Volume
9 - 2021
Edited by
Siva S. Panda, Augusta University, United States
Reviewed by
Tung Truong, University of Pittsburgh, United States
Assem Barakat, King Saud University, Saudi Arabia
Alexander Kastaniotis, University of Oulu, Finland
Updates

Check for updates
Copyright
© 2021 Rei Yan, Wakasuqui, Du, Groves and Wrenger.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Matthew R. Groves, m.r.groves@rug.nl; Carsten Wrenger, cwrenger@icb.usp.br
This article was submitted to Medicinal and Pharmaceutical Chemistry, a section of the journal Frontiers in Chemistry
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.